It's morally wrong for rich nations to hoard COVID-19 vaccine

February 16, 2021

BINGHAMTON, NY -- Rich nations should not engage in "vaccine nationalism" and keep the COVID-19 vaccine to themselves when poorer nations need them, according to Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York. Hassoun's paper, "Against Vaccine Nationalism," was published in the Journal of Medical Ethics.

While rich countries like the US and UK are starting to vaccinate their populations against COVID-19, poor countries may lack access to a vaccine for years. Canada, for instance, has already secured enough to vaccinate its entire population nine times over, and the US, European Union, UK, Australia, and Japan can vaccinate their populations between 2-8x.

"Vaccine nationalism is neither ethically justified, nor even in rich countries' long term self-interest," said Hassoun. "No one deserves the luck of their birth and few have much control over their country of residence. So when there are four ventilators per 12 million people in some developing countries, and people are being buried in cardboard boxes in mass graves, it is simply unconscionable to argue that wealthy countries can keep their vaccines to themselves or even help their populations first. Vaccine nationalism fails to respect basic human rights and the people that have them."

National leaders make promises and undertake commitments to protect their own, but they can't always prioritize their own citizens, said Hassoun. She believes that when national leaders engage in international efforts they adopt new role responsibilities - doing so often requires national leaders to act for the (global) common good.

"Consider an analogy - suppose a CEO is morally bound to advance the interests of stakeholders but learns that her company is profiting from polluting the Amazon. Is it acceptable for her to continue to allow her company to do so? Clearly not. Similarly, if her company could help avert a genocide or otherwise save many lives at some cost to shareholders, she might be morally bound to do so."

Hassoun also pointed out that it's in rich countries' long-term interests to equitably distribute vaccines.

"The COVID pandemic may continue to circle the globe for much longer (or indefinitely) if we do not fight it where the worst outbreaks are occurring," said Hassoun. "And herd immunity in rich countries is by no means guaranteed. Helping establish basic health infrastructure internationally (to not only vaccinate against COVID but a host of vaccine-preventable diseases) could greatly lower the global burden of disease."
-end-


Binghamton University

Related Vaccine Articles from Brightsurf:

Who should get the COVID-19 vaccine first?
Nineteen global health experts from around the world have proposed a new, three-phase plan for vaccine distribution -- called the Fair Priority Model -- which aims to reduce premature deaths and other irreversible health consequences from COVID-19.

Breakthrough with cancer vaccine
Scientists have developed a new cancer vaccine with the potential to activate the body's immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers.

How to improve the pneumococcus vaccine
Pneumococcus kills 1 million children annually according to the World Health Organization.

US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
In a new study, published April 7 in mBio, researchers from the University of Iowa and the University of Georgia demonstrate that a new vaccine fully protects mice against a lethal dose of MERS, a close cousin of COVID-19.

Coronavirus Vaccine: Where are we and what's next? (video)
You might have heard that COVID-19 vaccine trials are underway in Seattle.

Why isn't there a vaccine for staph?
A study from Washington University School of Medicine in St.

Exposing vaccine hesitant to real-life pain of diseases makes them more pro-vaccine
New research from Brigham Young University professors finds there is a better way to help increase support for vaccinations: Expose people to the pain and suffering caused by vaccine-preventable diseases instead of trying to combat people with vaccine facts.

Lifetime flu vaccine?
Another year, another flu vaccine because so far scientists haven't managed to make a vaccine that protects against all strains of flu.

On the horizon: An acne vaccine
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.

Read More: Vaccine News and Vaccine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.